Skip to content

ARGX.NL

argenx SE

Healthcare · Biotechnology · NL

—
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue8.7B4.2B2.2B1.2B410.7M
Cost of Revenue894.9M450.7M227.3M117.8M29.4M
Gross Profit7.8B3.7B2.0B1.1B381.3M
Operating Expenses
R&D Expense1.8B1.4B983.4M859.5M663.4M
SG&A Expense2.0B1.4B1.1B709.5M469.9M
General & Admin Expense532.5M930.8M748.4M507.4M354.0M
Selling & Marketing Expense240.2M429.2M307.0M202.1M116.0M
Other Expenses1.6B(75.9M)(54.2M)(35.5M)(31.6M)
Total Operating Expenses5.4B2.6B2.0B1.5B1.1B
Cost and Expenses6.3B3.1B2.2B1.7B1.1B
Operating Income (EBIT)2.4B1.1B(21.7M)(425.0M)(720.3M)
Non-Operating
Interest Income219.5M163.1M138.5M93.0M24.7M
Interest Expense5.1M4.1M2.2M904.0K2.2M
Net Interest Income214.4M159.0M136.3M92.1M22.5M
Other Non-Op Income/Expense389.1M224.0M106.8M120.6M(9.0M)
Non-Operating Income (excl Interest)(282.1M)(228.1M)(109.3M)(121.5M)6.8M
EBT (Pre-Tax Income)2.8B1.3B85.2M(304.5M)(729.3M)
Income Tax Expense137.7M(13.4M)(747.9M)(9.4M)(19.7M)
Bottom Line
Net Income2.6B1.3B833.0M(295.1M)(709.6M)
Earnings from Cont. Ops2.6B1.3B833.0M(295.1M)(709.6M)
Earnings from Discont. Ops—————
Bottom Line Net Income2.6B1.3B831.6M(295.1M)(709.6M)
Per Share
Basic EPS$42.66$21.14$13.92($5.16)($13.05)
Diluted EPS$40.41$19.63$12.78($5.16)($13.05)
Revenue Per Share$138.52$67.76$36.59$21.45$7.55
Shares
Basic Shares Outstanding62.7M61.3M59.9M57.2M54.4M
Diluted Shares Outstanding64.9M66.0M65.2M57.2M54.4M
Profitability Metrics
EBITDA2.7B1.3B105.2M(192.3M)(622.8M)
D&A45.2M28.1M17.5M111.3M104.3M
EBIT2.7B1.3B87.6M(303.6M)(727.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026